Quebec


View PCCN Locations in a larger map
BROME-MISSISQUOI
Contact: Peter Tetreault or Gib Rotheram
P: Peter Tetreault - (450) 242-1810 or Gib Rotheram -  (450) 242-2425
E:questco@sympatico.ca
Meet: 2nd Monday of every month
6:30pm
24 St. Paul Rd. (St. Paul Anglican Church)
Lac Brome, (Knowlton), QC

JEWISH GENERAL HOSPITAL - HOPE AND COPE
Contact: Yvon Patry
P: 514 340-3616
Meet: 3rd Tuesday of the month (except July)
Jewish General Hospital
9:30 AM
4635, Chemin de la Côte Ste Catherine, Montreal, H3W 1M1

PCCN MONTREAL WEST ISLAND
Contact: Fred Crombie 
P: 514 694-6412
E: fred.crombie@videotron.ca
 http://www.mtlwiprostcansupportgrp.ca/
Meet: 4th Thursday (except July, August, and December)
Sarto Desnoyers Comm. Centre, 1335 Lakeshore, Dorval
7:30 PM 

Groupe de soutien du cancer de la prostate - CHUM 
Contact: Claude Chiccoine
P: 514 890 8000 ext. 24619
E: prostatechum@gmail.com
Meet: 2nd Monday of the month (except July and August)
5:00 PM
Hospital Notre-Dame du CHUM (Plessis street parking)
1560, rue Sherbrooke Est, Montreal, Salon Lucien Lacoste, 1st Floor - Pavillon Mailloux

Groupe de soutien canadian pour le cancer de la prostate de Laval
Contact: Francois Diotte
P: 450 978-7666
Meet 1st Monday of the month (except June, July, August)
4:00 PM
Hospital de la Cite de la Sante, Local D-1021
1755, Boul. Rene-Laennec, Laval

Groupe de soutien du cancer de la prostate - Mauricie
Contact: Carole Morin
P: 819-375-3295
E: cancerquebec.trv@fqc.qc.ca
Meet: 1st Tuesday of the Month (except May to October)
4:00 PM
3110 Rue Louis Pasteur, Trois-Rivieres

 

 





Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rocco Rossi to wrap up successful 5-year tenure as Prostate Cancer Canada CEO

September 7, 2017 - TORONTO, ON - With mixed emotions, longstanding Prostate Cancer Canada (PCC) President and CEO, Rocco Rossi, formally announced today that his time leading the organization will officially come to a close as of December 31, 2017.
More

Mutation in prostate tumours shown to change epigenetic identity, the make-up of DNA

(TORONTO, Canada - Aug 7, 2017) -- Prostate cancer researchers have mapped the impact of an acquired mutation that alters epigenetic identity, the make-up of DNA, in about 50% of patient tumour samples.
More

Movember Foundation and Prostate Cancer Canada team up to turn research into results

July 26, 2017 - TORONTO, ON - Continuing their longstanding tradition of partnering to fund high quality Canadian prostate cancer research, Prostate Cancer Canada (PCC) and The Movember Foundation today announced two new projects with very real potential to make a tangible difference in the lives of men living with aggressive forms of prostate cancer.
More


Click here for news archive